Swartz Allison sold $61K of PGNY
Swartz Allison (EVP, GC) sold 2,398 shares of Progyny, Inc. (PGNY) at $25.46 on 2026-05-28 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
Because the sale is explicitly under a pre-arranged 10b5-1 plan, it is usually treated as non-discretionary and therefore has limited fundamental impact.
Market read
A routine insider sale disclosure; traders typically do not treat it as a standalone catalyst.
What to watch
The sale could be tax/compensation-related; the net effect depends on whether there are concurrent buys, option exercises, or changes in total insider holdings.
Background
This is an SEC Form 4 insider transaction (officer/direct holding) reported via EDGAR; it includes execution details and a stated 10b5-1 plan.
Ticker impact
Progyny disclosed an EVP/GC open-market sale of 2,398 shares ($61,053) under a pre-arranged 10b5-1 plan on May 28.
Likely minimal; any reaction is expected to be short-lived unless accompanied by other company-specific news.
The filing is a routine Form 4 transaction and explicitly states a pre-arranged 10b5-1 plan, reducing interpretive weight versus discretionary selling.
Market effects
No clear sector read-through; this is company-specific insider transaction disclosure.
None.
None.
Counterpoint
Even with 10b5-1, repeated insider selling can coincide with periods of reduced confidence or liquidity needs; monitor for clustering of sales vs buys.
Key entities
- issuerProgyny, Inc.
Company whose shares were sold by an EVP/GC via an open-market transaction under a 10b5-1 plan.
- insiderSwartz Allison
EVP, GC who sold 2,398 shares on May 28, 2026.
